跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACT METHYLPHENIDATE ER - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACT METHYLPHENIDATE ER
Authorized
STANDARD
ACT METHYLPHENIDATE ER
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2ad1b4c8d7ae7d7d
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
2ad1b4c8d7ae7d7d
Drug Approval Canada Name
ACT METHYLPHENIDATE ER
Product Name
ACT METHYLPHENIDATE ER
Status
Marketed
Status Date
2020-03-03
Original Market Date
2017-10-26
Din
02441934
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Schedule G (CDSA III)
Ahfs
28:20.32
Atc Original
N06BA04 METHYLPHENIDATE
Atc Name
n 06 ba 04
Aig Number
0107548004
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDE
18 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2ad1b4c8d7ae7d7d
Type
Standard
Back to Health Canada Approvals